The Role of Basal Insulin in the Management of Diabetes: Overcoming Inertia in Early Insulinization

This exclusive medical education activity is designed for healthcare professionals specializing in diabetes care and management. This webinar series will provide an in-depth exploration of the advancements in basal insulins, participants will also examine the challenges of therapeutic inertia the delay or reluctance to initiate insulin despite clinical indications and learn practical strategies to overcome barriers in early insulinization.

Join us for an engaging and informative session to explore the cutting-edge developments and future directions in basal insulin therapy, led by a distinguished diabetologist. The presentation will cover critical topics such as:

i. An overview of diabetes epidemiology

ii. The evolution of basal insulins

iii. Identifying the ideal basal insulin

iv. Understand how to overcome Inertia in early insulinization

v. Understand the rationale of initiating basal insulin therapy

The webinar will conclude with a highly interactive question and answer session, allowing participants to engage directly with the expert.

WHY ATTEND

1. Expert Insights: Gain knowledge from a leading diabetologist on the latest advancements in basal insulins.
2. Comprehensive Coverage: Understand the full spectrum of diabetes epidemiology and the evolution of basal insulins.
3. Interactive Learning: Participate in a dynamic Q&A session to clarify doubts and deepen your understanding.
4. Professional Development: Enhance your clinical practice with evidence-based information on insulin therapies.

PARTICIPANT CONSENT AND DATA PRIVACY NOTICE

By registering for The Role of Basal Insulin in the Management of Diabetes: Overcoming Inertia in Early Insulinization, you consent to participate in this training hosted by Continuous Education Services (CES) on behalf of Symbiotica Group. Your registration provides CES with the information required to facilitate the event and to issue CPD accreditation through the Medical and Dental Council (MDC). CES is committed to safeguarding your personal information: no personal data will be shared with Symbiotica Group. Data will be disclosed only to relevant regulatory bodies (e.g., MDC) strictly for the purpose of awarding CPD points. Participants may opt out of the meeting at any time without further obligation. Your privacy will be respected, and all participation records will be handled with the highest level of confidentiality.

SUPPORTED BY

This will be a LIVE virtual event. Thursday the 31st of July 2025. This event will be streamed live on this page.

Date: Thursday the 31st of July 2025

Time: 1500 - 1430 GMT (3:00-4:30 pm Local Time) 

Target Audience: Medical Doctors

Moderator: Dzifa Adeku - Medical Science Liaison-Symbiotica

The agenda is available to download in the downloads section.